JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Rapid Microarray Test for Herpesvirus Identification

Prove-it Herpes™ offers considerable cost savings for healthcare industry
by identifying eight herpesviruses simultaneously

Mobidiag has announced the new Prove-it™ Herpes test for the fast and reliable identification of herpesviruses. The microarray-based test takes less than three hours to complete and enables simultaneous identification of eight different human herpesviruses. Herpesviruses cause life-threatening central nervous system infections (CNSI), and rapid diagnosis improves likelihood of recovery. The new test is initially intended for research purposes, and Mobidiag plans to acquire European approval for use in clinical diagnostics later this year.

What makes Prove-it™ Herpes unique is that it combines different technologies and integrates them into a single easy-to-use and capable product,' says Pellosniemi, CEO of Mobidiag.

In addition to illnesses such as labial herpes, chickenpox and roseola, herpesviruses can also cause serious central nervous system infections such as encephalitis. Without appropriate treatment, mortality rate from these infections can be as high as 50%.

The sooner the pathogen is detected, the higher the likelihood of recovery. However, virus detection may be slow with current methods, and in severe suspected virus infection cases, medication is often started merely as a precaution. There are roughly four million of these suspected cases annually in the Industrial World, making testing and treating potential infections very expensive.

The Mobidiag test can detect and identify the viruses many times faster than conventional methods. Appropriate antiviral treatment can be administered sooner, and the level of potential permanent damage to the patient is decreased. Additionally, Mobidiag's test reveals multi-infections caused by several herpesviruses. The detection is also exceptionally sensitive to low viral loads, which are typical in the early stages of a central nervous system infection.

NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Mobidiag Oy View Company Information

Posted on March 17, 2008